A Study to Evaluate the Effectiveness of NuvaRing® to Prevent Pregnancies in Chinese Women (P06450)

• Status: Completed
• Trial end date: 2013-09-18
• Target enrollment: 0
• Participant gender: Female

Summary

This is a study to assess the effectiveness of NuvaRing® (SCH 900702) for the prevention of pregnancy in fertile Chinese women. The acceptability and safety of NuvaRing® will also be assessed and compared with that of Yasmin.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Desogestrel; Ethinyl Estradiol; NuvaRing

Criteria

Key Inclusion Criteria:

• Sexually active Chinese women, at risk for pregnancy and not planning to use condoms during trial medication use

• Women in need for contraception and willing to use a hormonal contraceptive method for 13 cycles

• Body mass index ≥18 and ≤29 kg/m^2

Key Exclusion Criteria:

• Contraindications for contraceptive steroids

• Abnormal cervical smear corresponding to indeterminate changes at screening

• Clinically relevant abnormal laboratory result at screening as judged by the investigator.